Dyspnea medical therapy: Difference between revisions
m (Bot: Removing from Primary care) |
|||
(4 intermediate revisions by 4 users not shown) | |||
Line 2: | Line 2: | ||
{{Dyspnea}} | {{Dyspnea}} | ||
{{CMG}} | {{CMG}} | ||
==Medical Therapy== | ==Medical Therapy== | ||
===Oxygen Supply=== | ===Oxygen Supply=== | ||
Line 41: | Line 40: | ||
[[Steroid]] use can be beneficial to pulmonary patients by reducing airway inflammation and by increasing [[vital capacity]] in chronic lung inflammation. However, [[steroid]]s have adverse effects, including muscle wasting and [[weakness]]. These potential problems need to be balanced against possible gains in lung function associated with this drug. | [[Steroid]] use can be beneficial to pulmonary patients by reducing airway inflammation and by increasing [[vital capacity]] in chronic lung inflammation. However, [[steroid]]s have adverse effects, including muscle wasting and [[weakness]]. These potential problems need to be balanced against possible gains in lung function associated with this drug. | ||
Cognitive-behavioral | Cognitive-behavioral approaches in patients with different pain syndromes, distraction, relaxation, and education about symptoms have modified the intensity of pain, increased tolerance, and decreased distress. Improvements in dyspnea and anxiety have been shown to follow distractions such as music during exercise, although long-term effects have been minimal. However, exercise in a monitored, supportive environment has been shown to be a powerful method of overcoming apprehension, anxiety, and/or fear associated with exertional dyspnea. | ||
==References== | ==References== | ||
Line 47: | Line 46: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category:Emergency medicine]] | [[Category:Emergency medicine]] | ||
[[Category:Pulmonology]] | [[Category:Pulmonology]] | ||
[[Category:Cardiology]] | [[Category:Cardiology]] | ||
[[Category: | [[Category:Needs overview]] | ||
Latest revision as of 21:31, 29 July 2020
Dyspnea Microchapters |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Medical Therapy
Oxygen Supply
Oxygen supply is the essential part of acute dyspnea management.
Exercise Training
Controlled studies have shown that dyspnea upon exertion decreases and exercise tolerance improves in response to exercise training, even in patients with advanced disease. It is now well established that for patients with COPD who remain breathless despite optimal drug therapy, exercise training can confer significant symptomatic benefits.
Pharmacologic Therapy
Two types of medications have proven useful in alleviating dyspnea: opiates and drugs that reduce anxiety. A number of studies have shown that opiates acutely relieve dyspnea and improve exercise performance in patients with COPD.
The drugs to reduce anxiety have the potential to relieve ventilatory response related to the available amounts of oxygen in the blood, as well as by lowering the emotional response to dyspnea.
Fans
The movement of cool air with a fan has been observed to reduce dyspnea in pulmonary patients. A decrease in the temperature of the facial skin alters feedback to the brain and modifies the perception of dyspnea. Cool air has been shown in normal volunteers to reduce dyspnea in response to excess carbon dioxide in the blood.
Altered Breathing Patterns
Breathing retraining including diaphragmatic breathing and pursed lip breathing has been advocated to relieve dyspnea in COPD patients. During a breathing retraining period, many patients adopt slower, deeper breathing techniques; however, they often resort to spontaneous, fast, shallow breathing patterns when the training ends.
Continuous Positive Airway Pressure (CPAP)
In various studies, CPAP has been shown to relieve dyspnea during asthma attacks, when patients are being weaned from ventilators, and during exercise sessions for patients with advanced COPD.
Nutrition
Several investigators have shown improvement in respiratory muscle function in response to short-term use of nutritional repletion by an intravenous route.
Positioning
Patients with COPD often change body position to improve dyspnea. They tend to lean forward to improve overall respiratory muscle strength and to reduce their symptoms.
Steroids
Steroid use can be beneficial to pulmonary patients by reducing airway inflammation and by increasing vital capacity in chronic lung inflammation. However, steroids have adverse effects, including muscle wasting and weakness. These potential problems need to be balanced against possible gains in lung function associated with this drug.
Cognitive-behavioral approaches in patients with different pain syndromes, distraction, relaxation, and education about symptoms have modified the intensity of pain, increased tolerance, and decreased distress. Improvements in dyspnea and anxiety have been shown to follow distractions such as music during exercise, although long-term effects have been minimal. However, exercise in a monitored, supportive environment has been shown to be a powerful method of overcoming apprehension, anxiety, and/or fear associated with exertional dyspnea.